Cargando…
The association of aspirin use with overall survival of patients with inoperable non-small cell lung cancer: a retrospective study
BACKGROUND: Studies have indicated that individuals taking aspirin have a reduced risk of cancers and have also established chemo-preventive benefit of aspirin in colorectal cancer. However, research on the association between aspirin use and the survival in patients with lung cancer has revealed in...
Autores principales: | Chuang, Min-Chun, Yang, Yao-Hsu, Hsieh, Meng-Jer, Lin, Yu-Ching, Yang, Tsung-Ming, Chen, Pau-Chung, Hung, Ming-Szu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8607685/ https://www.ncbi.nlm.nih.gov/pubmed/34809588 http://dx.doi.org/10.1186/s12885-021-08999-8 |
Ejemplares similares
-
Survival benefit associated with metformin use in inoperable non-small cell lung cancer patients with diabetes: A population-based retrospective cohort study
por: Chuang, Min-Chun, et al.
Publicado: (2018) -
Low cardiac dose and neutrophil-to-lymphocyte ratio predict overall survival in inoperable esophageal squamous cell cancer patients after chemoradiotherapy
por: Ho, Yu-Chieh, et al.
Publicado: (2021) -
Daily Aspirin Reduced the Incidence of Hepatocellular Carcinoma and Overall Mortality in Patients with Cirrhosis
por: Lee, Chern-Horng, et al.
Publicado: (2023) -
Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs
por: Hung, Ming-Szu, et al.
Publicado: (2019) -
Concurrent proton-pump inhibitors increase risk of death for lung cancer patients receiving 1st-line gefitinib treatment - a nationwide population-based study
por: Fang, Yu-Hung, et al.
Publicado: (2019)